Effects of the CD33-targeted drug gemtuzumab ozogamicin (Mylotarg) on growth and mediator secretion in human mast cells and blood basophils
2007 ◽
Vol 35
(1)
◽
pp. 108-116
◽
Keyword(s):
2010 ◽
Vol 151
(1)
◽
pp. 38-45
◽
Keyword(s):
Keyword(s):
2010 ◽
Vol 91
(5)
◽
pp. 1256-1261
◽